Refinement of the Clinical Scenario Evaluation Framework for Assessment of Competing Development Strategies with an Application to Multiple Sclerosis

被引:0
|
作者
Tim Friede
Richard Nicholas
Nigel Stallard
Susan Todd
Nicholas Parsons
Elsa Valdés-Márquez
Jeremy Chataway
机构
[1] Warwick Medical School,
[2] The University of Warwick,undefined
[3] Imperial College Healthcare NHS Trust,undefined
[4] Applied Statistics,undefined
[5] University of Reading,undefined
[6] National Hospital for Neurology and Neurosurgery,undefined
[7] University Medical Center Göttingen,undefined
[8] Department of Medical Statistics,undefined
关键词
Clinical scenario evaluation; Drug development program; Clinical development; Adaptive seamless design; Multiple sclerosis;
D O I
暂无
中图分类号
学科分类号
摘要
When competing strategies for development programs, clinical trial designs, or data analysis methods exist, the alternatives need to be evaluated in a systematic way to facilitate informed decision making. Here we describe a refinement of the recently proposed clinical scenario evaluation framework for the assessment of competing strategies. The refinement is achieved by subdividing key elements previously proposed into new categories, distinguishing between quantities that can be estimated from preexisting data and those that cannot and between aspects under the control of the decision maker from those that are determined by external constraints. The refined framework is illustrated by an application to a design project for an adaptive seamless design for a clinical trial in progressive multiple sclerosis.
引用
收藏
页码:713 / 718
页数:5
相关论文
共 50 条
  • [11] The Multiple Sclerosis Outcomes Assessment Consortium: Accelerating Development of Treatments for Multiple Sclerosis
    LaRocca, Nicholas
    Hudson, Lynn
    Rudick, Richard
    NEUROLOGY, 2013, 80
  • [12] Epidemiology and clinical assessment of spasticity in multiple sclerosis
    Bensmail, D.
    Vermersch, P.
    REVUE NEUROLOGIQUE, 2012, 168 : S45 - S50
  • [13] Climate change and multiple sclerosis: Clinical challenges and strategies
    Balshi, Alexandra
    MULTIPLE SCLEROSIS JOURNAL, 2025,
  • [14] Dysphagia In Multiple Sclerosis Patients: Diagnostic And Evaluation Strategies
    Ansari, Noureddin Nakhostin
    Tarameshlu, Maryam
    Ghelichi, Leila
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2020, 10 : 15 - 28
  • [15] Factor analysis in the development and refinement of clinical assessment instruments
    Floyd, FJ
    Widaman, KF
    PSYCHOLOGICAL ASSESSMENT, 1995, 7 (03) : 286 - 299
  • [16] Cognitive assessment in multiple sclerosis clinical care: A qualitative evaluation of stakeholder perceptions and preferences
    Elwick, Hannah
    Smith, Laura
    Mhizha-Murira, Jacqueline R.
    Topcu, Gogem
    Leighton, Paul
    Drummond, Avril
    Evangelou, Nikos
    das Nair, Roshan
    NEUROPSYCHOLOGICAL REHABILITATION, 2022, 32 (07) : 1456 - 1474
  • [17] Preclinical and clinical evaluation of alemtuzumab in multiple sclerosis
    Siders, William
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [18] Clinical Utility and Psychometric Properties of the Functional Assessment of Multiple Sclerosis for Individuals With Multiple Sclerosis
    Smith, Evan L.
    Driskell, Lucas D.
    REHABILITATION PSYCHOLOGY, 2016, 61 (02) : 218 - 218
  • [19] Clinical development of mycophenolate mofetil in multiple sclerosis
    Davies, S. L.
    Moral, M. A.
    DRUG NEWS & PERSPECTIVES, 2006, 19 (10) : 632 - 633
  • [20] Development of an APP (ABOUTCOME) for evaluation in multiple sclerosis
    Solaro, C.
    Di Giovanni, R.
    Grange, E.
    Tacchino, A.
    Spirito, M. M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (2_SUPPL) : 32 - 32